[1]
Clerbaux, L.-A., Amigó, N. , Amorim, M.J. , Bal-Price, A., Batista Leite, S., Beronius, A., Bezemer, G.F.G., Bostroem, A.-C., Carusi, A., Coecke, S., Concha, R., Daskalopoulos, E.P., Debernardi, F., Edrosa, E., Edwards, S.W., Filipovska, J., Garcia-Reyero, N. , Gavins, F.N.E., Halappanavar, S., Hargreaves, A.J., Hogberg, H.T., Huynh, M.T., Jacobson, D., Josephs-Spaulding, J. , Kim, Y.J. , Kong, H.J. , Krebs, C.E., Lam, A., Landesmann, B. , Layton, A., Lee, Y.O. , Macmillan, D.S., Mantovani, A. , Margiotta-Casaluci, L. , Martens, M. , Masereeuw, R., Mayasich, S.A., Mei, L.M. , Mortensen, H., Munoz Pineiro, A. , Nymark, P., Ohayon, E., Ojasi, J., Paini, A., Parissis, N. , Parvatam, S. , Pistollato, F. , Sachana, M., Sørli, J.B., Sullivan, K.M., Sund, J., Tanabe, S. , Tsaioun, K. , Vinken, M. , Viviani, L. , Waspe, J., Willett, C. and Wittwehr, C. 2022. COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease – 3rd CIAO AOP Design Workshop. ALTEX - Alternatives to animal experimentation. (Jan. 2022). DOI:https://doi.org/10.14573/altex.2112161.